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S_umary No measurable amounts of matrix metalloproteinases (MMPs) were produced by human breast
adenocarcinoma cell lines MCF-7 and BT-20 in culture. When MCF-7 cells were co-cultured with human
dermal fibroblasts enhanced production of precursors of MMP-l (interstitial collagenase), MMP-2 (gelatinase
A), MMP-3 (stromelysin 1) and tissue inhibitor of metalloproteinase type (TIMP-1) was observed.
Immunohistochemical studies indicated that these pro-MMPs originated primarily from the fibroblasts,
suggesting that MCF-7 cells have a stimulatory effect on stromal cells to produce at least three pro-MMPs and
TIMP-l. BT-20 cells also enhanced the production of pro-MMP-2 and TIMP-1 in the dermal fibroblasts, but
not of pro-MMP-l and pro-MMP-3. Normal mammary epithelial cells promoted only TIMP-l production. To
investigate further the stimulatory factors from MCF-7 cells, the conditioned medium and the cell membrane
were prepared and examined. The cell membrane fraction enhanced the production of pro-MMP-1 and -3 and
TIMP-1, but not of pro-MMP-2. The conditioned medium, on the other hand, augmented the production of
all four proteins in the fibroblasts. These observations suggest that breast adenocarcinoma MCF-7 cells in
culture produce both soluble and membrane-bound factor(s) which stimulate the production of pro-MMPs
and TIMP-1 in neighbouring stromal cells, but the factor(s) released into the medium and that associated with
cell membranes are probably different. Such communication between the normal and malignant cell types may,
in part, assist the cancer cells to invade and metastasise.
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The degradation of extracellular matrix components (ECM),
especially basement membrane type IV collagen, is consider-
ed to be a key event for tumour cell invasion and metastasis.
Recent studies have indicated that matrix metalloproteinases
(MMPs) including MMP-2 (gelatinase A) (Gabrisa et al.,
1987; Ura et al., 1989), MMP-3 (stromelysin 1) (Matrisian
and Bowden, 1990) and MMP-9 (gelatinase B) (Baylin et al.,
1988; Wilhelm et al., 1989; Yamagata et al., 1989) play major
roles in the degradation of the extracellular matrix (ECM) in
tumour invasion. In particular, the secretion of MMP-9 (Ber-
nhard et al., 1990; Okada et al., 1990) and/or MMP-2 (Naka-
jima et al., 1987; Liotta and Stetler-Stevenson, 1989; Ura et
al., 1989) by cancer cells has been shown to be closely related
to their metastatic potential using experimental metastasis
models. Immunohistochemical studies have indicated that
MMP-2 is highly expressed in more invasive and metastatic
cancer tissues (Monteagudo et al., 1990). A significant role of
MMPs in cancer cell metastasis has also been suggested by
the observations that exogenously added tissue inhibitors of
metalloproteinases (TIMPs) or antibodies to MMPs (Shultz
et al., 1988; Monteagudo et al., 1990; Albini et al., 1991;
DeClerck et al., 1991; Liotta and Stetler-Stevenson, 1991) or
transfection of TIMP-2 in cancer cells (DeClerck et al., 1992)
results in a loss of the invasive and metastatic ability of
cancer cells.
To clarify the role of MMPs in cancer cell invasion and/or
metastasis, most attention has been given to evaluating the
cancer cells for their ability to produce MMPs. On the other
hand, several reports have emphasised the importance of
tumour cell-fibroblast interactions in the regulation of
MMP-1 (interstitial collagenase) production in neoplasia
(Biswas, 1982, 1984; Biswas et al., 1982; Dabbous et al.,
1983; Baici et al., 1984; Golslen et al., 1985). Biswas (1982,
1984) isolated a factor stimulating collagenase production
from tissue extracts of the mouse melanoma cell line, B-16,
and the human lung carcinoma cell line, LX-1. The addition
of the purified factor from LX-1 cell membranes to cultured
fibroblasts augmented the production of MMP-1, MMP-2
and MMP-3 accompanied by an increase in their mRNA
levels (Prescott et al., 1989; Kataoka et al., 1993). Further-
more, Basset et al. (1990) have reported that human breast
carcinoma expresses the stromelysin 3 (MMP-11) gene, a new
member of the MMP gene family, in the stromal cells sur-
rounding invasive neoplastic cells. The recombinant MMP-l 1
was shown to have weak proteolytic activity (Murphy et al.,
1993). These observations suggest that the enhanced produc-
tion of MMPs by cancer cell-fibroblast interaction may
contribute to metastasis in breast carcinoma.
In this report, we demonstrate that human breast adeno-
carcinoma MCF-7 cells, but not normal mammary epithelial
cells, spontaneously produce some stimulating factors that
augmented the production of pro-MMP-l, -2 and -3 and
TIMP-1 in human normal dermal fibroblasts.
Materials and methods
Materials
The following reagents were obtained commercially: Eagle's
minimum essential medium (MEM) from Grand Island Bio-
chemical, Grand Island, NY, USA; fetal bovine serum (FBS)
from MA Bioproducts, Walkersville, MD, USA; alkaline
phosphatase-conjugated donkey anti-(sheep IgG)IgG, alka-
line phosphatase-conjugated goat anti-(rabbit IgG)IgG, lact-
albumin hydrolysate (LAH), 4-aminophenylmercuric acetate
(APMA), 5-bromo-4-chloro-3-indolyl phosphate and nitro-
blue tetrazolium from Sigma, St Louis, MO, USA; sheep
anti-(human pro-MMP-l), anti-(human MMP-3) and anti-
(human TIMP-1) and rabbit anti-(human pro-MMP-2) anti-
bodies were prepared as described previously (Takahashi et
al.. 1993; Imada et al., 1994). Other reagents used were the
same as in a previous paper (Ojima et al., 1989).
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Cells and culture conditions
The oestrogen-dependent human breast adenocarcinoma cell
line, MCF-7, and the oestrogen-independent adenocarcinoma
cell line, BT-20 (Kosano and Takatani, 1988, 1989), were
kindly provided by Dr Hiroshi Kosano (Faculty of Phar-
maceutical Science, Teikyo University, Kanagawa, Japan).
Normal human skin fibroblasts were kindly donated by Dr
Toshiaki Takezawa (Grace Japan, Kanagawa, Japan). MCF-
7 cells, BT-20 cells and skin fibroblasts were subcultured in
75 cm2 tissue culture flasks with MEM-10O (v/v) FBS. The
confluent cells were passaged by treating them with 0.125%
trypsin-0.02% EDTA. Normal human mammary epithelial
cells (Mammary pack) were commercially obtained from
Clonetics (San Diego, CA, USA). This cell line was estab-
lished from a 50-year-old woman and characterised as a
typical mammary epithelial cell by immunostaining with
cytokeratin 14 and 18 antibodies. The normal mammary
epithelial cells were subcultured with serum-free mammary
epithelial cell growth medium (H{EGM) containing epidermal
growth factor, insulin and hydrocortisone and then passaged
according to the manufacturer's instructions.
Co-culture ofhuman dermalfibroblasts with MCF-7 cells and
treatment ofdermal cells with MCF-7 cell conditioned medium
or cell membrane
A constant number of MCF-7, BT-20 or normal epithelial
cells suspended in 10% (v/v) FBS-MEM were inoculated
onto the confluent dermal fibroblasts (12 x 104 cells) in 12
multiwell plates and incubated for 24 h to attach each other,
and then the cells were washed twice with 0.2% (w/v) LAH-
MEM and cultured for a further 48 h in the same medium to
examine the production of pro-MMPs and TIMP-1.
Treatment of human dermal fibroblasts with the MCF-7
cell conditioned medium or cell membrane of MCF-7 cells
was similarly carried out in 0.2% (w/v) LAH-MEM for
48 h.
Preparation ofthe MCF-7 cell conditionedmediwn andcell
membrane ofMCF-7 cells
Confluent MCF-7 cells in 75 cm2 flasks were washed once
with 0.2% (w/v) LAH-MEM and then cultured for 48 h.
The harvested culture medium was centrifuged at 1200g for
10 min and the supernatant was concentrated 100-fold by
ultrafiltration with Filtrone OM-5 membrane (molecular
weight cut-off 5000, Corning, Japan), and then filtered
through 0.45pm pore sized membrane to steilise it. This
conditioned medium was stored at -20C until use.
The cell membrane of MCF-7 cells was also prepared
according to the method of Biswas and Nugent (1987) with a
slight modification. Confluent MCF-7 cells in 100-mm-dia-
meter dishes were rinsed three times with Ca2+_ and Mg2+-
free phosphate-buffered saline [PBS(-)J and then scraped off
with a rubber policeman. The cells were suspended in 50 mM
Tris-HCI-0.24 M sucrose (pH 7.4) and the suspension was
sonicated with three 30 s bursts at 4'C. The sonicate was
centrifuged at 500 g for 20min, and then the supernatant
collected was centrifuged again at 100 000g for 1 h at 4 C.
The resultant pellet was suspended in PBS(-) and dialysed
exhaustively against the same buffer for 2 days at 4-C.
Gelatin zymography
The activity of gelatinolytic enzyme in culture media was
detected by electrophoresis in 7.5% (w/v) acrylamide gel
co-polymerised gelatin (Difco Laboratonres, Detroit, MI,
USA) at a final concentration of 0.6 mgml['. Briefly, a IOid
portion of harvested culture medium was mixed with the
sample buffer of SDS-polyacrylamide gel electrophoresis
(SDS-PAGE; Laemmli, 1970), and then electrophoresed
without boiling under non-reducing conditions. After electro-
phoresis, SDS in the gel was removed by rinsing with 50 mM
Tris-HCI-5 mM calcium chloride-l gM zinc chloride (pH
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Fgwe 1 Production of pro-MMPs and TIMP-l by human der-
mal fibroblasts co-cultured with normal or neoplastic breast cells.
Confluent dermal fibroblasts (12 x 104 cells) at the 18th passage
in 12 multiwell plates were co-cultured with normal or neoplastic
breast cells (6 x 104 cells) in 1.0ml of 10% (v/v) FBS-MEM.
After 24h, cells were washed with 0.2% (w/v) LAH-MEM and
then incubated for a further 48 h in the same medium. The
culture media harvested were concentrated with tnchloroacetic
acid and subjected to Western blotting as described in the text.
The relative amounts of each protein were quantified by den-
sitometnc scanning taking the control cells as I and are indicated
at the top of each panel. (a) Pro-MMP-1; (b) pro-MMP-3; (c)
pro-MMP-2; (d) TIMP-1. Lane 1, human dermal fibroblasts; lane
2, human dermal fibroblasts co-cultured with human normal
mammary epithelial cells; lane 3, human dermal fibroblasts co-
cultured with MCF-7 cells; lane 4, human dermal fibroblasts
co-cultured with BT-20 cells; lane 5, human mammary epithelial
cells; lane 6, MCF-7 cells; lane 7, BT-20 cells.
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Fugwe 2 MCF-7 cell-dependent production of pro-MMPs and
TIMP-1 from human dermal fibroblasts. Confluent dermal fibro-
blasts (12 x 104 cells) at the 17th passage in 12 multiwell plates
were co-cultured with MCF-7 cells at the ratios indicated and the
other culture conditions were the same as in Figure 1. The culture
media harvested were subjected to Western blotting for pro-
MMPs and TIMP-1 and gelatin zymography for pro-MMPs and
TIMP-1. The relative amounts of each protein produced were
quantified and shown as described in Figure 1. (a) Pro-MMP-1;
(b) pro-MMP-3; (c) A = pro-MMP-2 zymography and B =
Western blotting; (d) TIMP-1.
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F7.5) containing 2.5% (v/v) Triton X-100 and then the gel was
incubated at 37C for 1.5 h in the same buffer without Triton
X-100. The gel was stained with 0.1% (w/v) Coomassie
brilliant blue in 50% (v/v) methanol-20% (v/v) acetic acid,
and then destained with 1% (v/v) formic acid-30% (v/v)
methanol.
Immunofluorescence localisation ofMMPs
This was carried out as described previously (Sasaguri et al.,
1992). Briefly, human dermal fibroblasts were co-cultured
with or without MCF-7 cells for 24 h, followed by treatment
with iLgml-' monensin for a further 4 h before fixation
with cold acetone. The fixed cells were incubated with anti-
bodies to MMP for 1 h, and then treated with fluorescein
isothiocyanate-conjugated second antibodies to sheep or rab-
bit IgG for 1 h. After washing with PBS(-), localisation -of
the fluorescence and cell morphology were observed under a
laser scan microscope (Zeiss LSM 310, Carl Zeiss, Oberko-
chen, Germany).
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Assayfor gelatinolytic activit)
Gelatinolytic activity in the culture medium was measured by
using heat-denatured ['4Cjacetylated type I collagen as a
substrate after the activation of pro-MMP-2 with 1 mm
APMA as described previously (Ishibashi et al., 1987). One
unit of the gelatinolytic activity hydrolysed 1 iLg of gelatin
per minute-' under the conditions used.
Western blotting
Pro-MMPs in culture media were analysed by Western blot-
ting with specific sheep anti-(human pro-MMP-1) and anti-
(human MMP-3) antibodies and rabbit anti-(human pro-
MMP-2) antibody as described previously (Ito and Nagase,
1988). The sample collected from triplicate wells for each
treatment was concentrated with 3.3% (w/v) trichloracetic
acid, dissolved in SDS-PAGE sample solution, and subject-
ed to SDS-PAGE using 10% (for pro-MMPs) and 12.5%
(for TIMP-1) acrylamide gel under reducing conditions. The
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Fugwe 3 Immunoftuorescence mirographs ofhuman dermal fibroblasts co-cultured with MCF-7 cells. Human dermal fibroblasts
and MCF-7 cells were co-cultured for 24 h in 10% (v/v) FBS-MEM, and then treated with Ilgml-1 monensin for another 4h to
enhance the intracellular accumulation of MMPs. The cultured cells were reacted first with anti-(human pro-MMP)serum and then
with fluorescein-conjugated second antibodies as described in the text. Immunostaining of the co-culture of fibroblasts and MCF-7
cells (a, c and e), and differential interface contact images of the cell preparation on a laser scan microscopy at the identical
positions (b, d and f, respectively) are shown. Each asterisk on the laser scan micrographs indicates fibroblasts positive for
immunostaining of MMPs. (a) and (b) Pro-MMP-l; (c) and (d) pro-MMP-2; (e) and (f) pro-MMP-3. the bar represents lOpm in
all cases.
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separated proteins were electrotransferred to a nitrocellulose
filter, and then the filter was reacted with the MMP or
TIMP-1 antibody, which was then complexed with alkaline
phosphatase-conjugated donkey anti-(sheep IgG)IgG or goat
anti(rabbit IgG)IgG. Immunoreactive MMPs or TIMP-I
were visualised indirectly with 5-bromo-4-chloro-3-indolyl
phosphate and nitroblue tetrazolium.
Results
Changes in pro-MMPs and TIMP-J production in human
dernalfibroblasts co-cultured with MCF-7, BT-20 and normal
hwman mammary epithelial cells
When human dermal fibroblasts were co-cultured with
oestrogen-dependent adenocarcinoma MCF-7 cells, oestro-
gen-independent adenocarcinoma BT-20 cells or normal
human mammary epithelial cells, MCF-7 cells enhanced the
production of both pro-MMP-l and -3, whereas BT-20 and
normal mammary epithelial cells did not modulate the pro-
duction of these pro-MMPs significantly (Figur9(la and
lb).
The production of pro-MMP-2 was augmented by both
types of adenocarcinoma cells, but not by normal epithelial
cells (Figure lc). The increase in pro-MMP-2 production was
further confirmed by gelatin zymography, but pro-MMP-9
was not detected (data not shown). In contrast, TIMP-1
production by dermal fibroblasts was augmented by co-
culturing with MCF-7, BT-20 and normal epithelial cells
(Figure ld). These three cell lines did not produce any detect-
able amounts of pro-MMPs and TIMP-1 (Figures la-d,
Figue 4 Effect of the cell membrane of MCF-7 ceUs on the
production of pro-MMPs and TIMP-1 from human dermal
fibroblasts. A cell membrane fraction prepared from MCF-7 cells
was sonicated in 0.2% (w/v) LAH-MEM to make a
homogeneous suspension- Confluent dermal fibroblasts (12 x 10I
cells) at the 19th passage in 12 multiwell plates were treated with
the cell membrane suspension corresponding to 6 x 10' cells of
MCF-7 for 48 h. Microscopic examination of the treated cells
indicated uniform spreading of cell membrane debris on fibrob-
lasts. The harvested culture media were subjected to Western
blotting and/or gelatin zymography. The relative amounts of each
protein produced were quantified as described in Figure 1. (a)
Pro-MMP-1; (b) pro-MMP-3; (C) A = zymography and
B = Western blotting for pro-MMP-2; (d) TIMP-1. Lane 1, un-
treated human dermal fibroblasts; lane 2, human dermal fibrob-
lasts treated with the MCF-7 cell membrane; lane 3, MCF-7 cell
membrane alone.
lines 5-7) even when they were treated with human recom-
binant interleukin la or 12-O-tetradecanoyl phorbol 13-ace-
tate (data not shown), suggesting that pro-MMPs and TIMP-
1 were most probably produced by human dermal fibro-
blasts. To investigate this further, MCF-7 cells that exerted
the greatest effect on the production of MMPs were used for
subsequent experiments.
We first examined the effect of the number of MCF-7 cells
on the production of pro-MMPs and TIMP-1. When conflu-
ent normal fibroblasts were cultured with various cell
numbers of MCF-7, the production of pro-MMPs and
TIMP-1 coordinately increased in an MCF-7 cell-number
dependent manner; the maximum relative increases in pro-
MMP-1, -2 and -3 and TIMP-1 were about 3.7-, 4.3-, 2.4-
and 1.3-fold respectively (Figure 2). Zymographic analysis
indicated that all MMP-2 in the culture media was in a latent
form (Figure 2c).
Immunolocalisation ofMMPs in dermalfibroblasts co-cultured
with MCF-7 cells
To further identify the pro-MMP-producing cells in the
above co-culture system, immunohistochemical staining for
MMP-1, -2 and -3 was performed. As shown in Figure 3,
laser scan microscopy reveals two types of differential inter-
face contact images; one was uniformly small and round or
polygonal cells (MCF-7 cells) frequently forming clusters,
and the other type was relatively large, flattened and spindle-
shaped cells (dermal fibroblasts) (Figure 3b, d and f). The
immunofluorescence corresponding to MMP-1, -2 and -3 was
localised primarily in the latter fibroblast cells (Figure 3a, c
and e). These results further support the hypothesis that the
increased production of pro-MMP-1, -2 and -3 by the co-
culture resulted predominantly from the activated dermal
fibroblasts.
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Fgue 5 Effect of MCF-7 cell conditioned medium on the pro-
duction of pro-MMPs and TIMP-1 from human dermal fibro-
blasts. Confluent human dermal fibroblasts (12 x 10' cells) at the
18th passage in 12 multiwell plates were treated with concen-
trated MCF-7 cell conditioned medium obtained from 48 h cul-
ture of 6 x 10' clls in 0.2% (w/v) LAH-MEM for 48 h, and
then the harvested culture media were subjected to Western
blotting and/or gelatin zymography. The relative amounts of
protein produced in each case were quantified and shown as
described in Figure 1. (a) Pro-MMP-1; (b) pro-MMP-3; (c) A =
pro-MMP-2 zymography and B = Western blotting; (d) TIMP-1.
Lane 1, untreated human dermal fibroblasts; lane 2, human
dermal fibroblasts treated with MCF-7 ceUl conditioned medium;
lane 3, MCF-7 cell conditioned medium alone.
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Figwe 6 Effect of MCF-7 cell conditioned medium on the
gelatinolytic activity produced by human dermal fibroblasts.
Confluent human dermal fibroblasts at the 12th passage were
treated with MCF-7 cell conditioned medium as described in
Figure 5. The activation of pro-MMP-2 with APMA and assay
for gelatinolytic activity in the culture media were done as des-
cribed in the text. Results are shown as the means ± s.d. of three
wells. **Significantly different from untreated cells (P<0.O1).
Effect of the MCF-7 cell conditioned mediun and the MCF-7
cell membrane on theproduction ofpro-MMPs and TIMP-1 in
hunan dermalfibroblasts
To investigate whether the pro-MMPs and TIMP-1 produc-
tion-stimulatory activity of MCF-7 cells is due to a soluble
factor secreted by MCF-7 cells or to cell-cell contact, we
examined the stimulatory activity in conditioned medium and
in cell membranes prepared from MCF-7 cells. When human
dermal fibroblasts were treated with cell membranes, the
production of pro-MMP-l and -3 and TIMP-l, but not that
of Pro-MMP-2, was augmented (Figure 4), whereas the con-
ditioned medium coordinately augmented the production of
all four proteins in the fibroblasts (Figure 5). No significant
augmentation of pro-MMP-2 production was observed even
when the amount of membrane added to fibroblasts was
increased, under which conditions the production of the two
other pro-MMPs was greatly enhanced. It is therefore likely
that the stimulatory factor(s) secreted in the culture medium
is different from that associated with MCF-7 cell membranes.
The apparent MMP activities are controlled by the balance
between active MMPs and TIMPs. We, therefore, examined
whether the above changes in pro-MMPs and TIMP-l pro-
duction caused by the MCF-7 cell-conditioned medium
resulted in an increase in apparent MMP activities. As shown
in Figure 6, when human dermal fibroblasts were treated
with various concentrations of the MCF-7 conditioned
medium, the apparent gelatinolytic activity in the culture
medium detected after APMA activation increased signifi-
cantly, indicating that the overall increase in production of
pro-MMPs was greater than that of TIMPs.
Dsio
In this report, we have demonstrated that two adenocar-
cinoma cell lines which do not produce any significant
amount of pro-MMPs augment the production of pro-MMPs
by normal stromal cells. When normal dermal fibroblasts
were co-cultured with oestrogen-dependent adenocarcinoma
MCF-7 cells, the production of pro-MMP-l, -2 and -3 and
TIMP-l in normal fibroblasts was greatly enhanced, whereas
oestrogen-independent adenocarcinoma BT-20 cells increased
only pro-MMP-2 and TIMP-1. The difference in effect
between MCF-7 and BT-20 on the production of pro-MMPs
may be attributed to the cell types rather than to the status
of oestrogen receptor, since MCF-7 cells cultured in 10%
(v/v) oestrogen-depleted FBS-MEM similarly augumented
the production of both pro-MMPs and TIMP-1 in fibroblasts
(data not shown). It is, furthermore, noteworthy that normal
mammary epithelial cells increased only the production of
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TIMP-l. These results indicate the specific stimulatory effects
of breast adenocarcinoma cells on the production of pro-
MMPs and TIMP-1 in the normal dermal fibroblasts.
To investigate further the effect of cancer cell-normal cell
interaction, we examined the distribution of pro-MMPs and
TIMP-1 production stimulatory activity in the cell membrane
and the conditioned medium of MCF-7 cells. Our observa-
tions indicate that this cell line produces at least two species
or sets of stimulatory factors since the conditioned medium
augmented the production of pro-MMP-l, -2 and -3 and
TIMP-1, whereas the cell membrane enhanced the produc-
tion of pro-MMP-l, pro-MMP-3 and TIMP-1 but not that
of pro-MMP-2. The membrane-bound tumour cell-derived
collagenase stimulatory factor (TCSF) was isolated from
human lung carcinoma cells by Ellis et al. (1989). This factor
enhances the expression of pro-MMP-1 and -3 mRNAs in
the human colon fibroblast cell line CCD-18 and other
human fibroblasts, and it also accelerates the conversion of
pro-MMP-2 to an active form (Kataoka et al., 1993). The
factor(s) associated with the MCF-7 cell membranes, how-
ever, did not influence the activation of pro-MMP-2. Thus, it
is likely that the factor(s) in MCF-7 cells is not TCSF.
By contrast, the stimulatory activities found in the condi-
tioned medium of MCF-7 cells appear to be distinct from
those on the cell surface. It has been reported that MCF-7
cells produce several growth factors, including transforming
growth factor m (TGF-x) (Bates et al., 1988; Kosano et al.,
1992), TGF-0 (Knabbe et al., 1987) and insulin-like growth
factor I (Huff et al., 1986). TGF-a and TGF-0 are known to
modulate the production of MMPs in several cell types.
Indeed, we have observed that a high concentration (> 10 ng
ml-') ofTGF-x augments the production ofpro-MMP-l and
-3 and TIMP-1 without affecting the production of pro-
MMP-2 in a dose-dependent manner (A Ito, S Nakajima and
Y Mori, unpublished observation). On the other hand, TGF-
0 at concentrations greater than 100pgml-1' increases the
production of pro-MMP-2 and TIMP-1, but suppresses the
production of pro-MMP-1 and -3 in human dermal fibrob-
lasts (A Ito, S Nakajima and Y Mori, unpublished observa-
tion). In addition, studies by Kosano et al. (1992) and
Knabbe et al. (1987) suggest that the effective concentrations
of these cytokines are higher than the concentrations usually
found in the culture media of MCF-7 cells. It is therefore
unlikely that TGF-a and/or TGF-P are the primary factors
from MCF-7 cells that augmented the production of pro-
MMPs and TIMP-1 in human dermal fibroblasts.
The invasive and metastatic properties of MCF-7 cells
have been reported, but the relation between these properties
and their ability to produce matrix-degrading enzymes has
not been clarified (Shafie and Liotta, 1980; Gelmann et al.,
1992). Recently, Shi et al. (1993) reported that MCF-7 cells
produce a novel 80 kDa gelatinolytic metalloprotease which
plays a significant role in cancer cell invasion and metastasis
when MCF-7 cells are inoculated into nude mice. However,
we did not observe any gelatinolytic activities in our zymo-
graphic analysis of the MCF-7 conditioned medium. This
discrepancy may be due to the different assay conditions, i.e.
we examined the gelatinolytic activity using the unconcen-
trated culture medium of MCF-7 cells, whereas Shi et al.
(1993) used a 20-fold concentrated medium.
In conclusion, the ability of MCF-7 cells to augment the
production of pro-MMPs in surrounding normal fibroblasts
is probably one of the important properties for MCF-7 cell
invasion and metastasis. Our present data may partly explain
why the MMP gene is often predominantly expressed in the
stromal cells that surround invasive neoplastic cells (Basset et
al., 1990; Pyke et al., 1992). Purification and characterisation
of the factor(s) in the conditioned culture medium of MCF-7
cells are now in progress.
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